Author:
Acosta Walter,Ayala Jorge,Dolan Maureen C.,Cramer Carole L.
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Grabowski, G. Treatment perspectives for the lysosomal storage diseases. Expert Opin Emerg Drugs 13, 197–211 (2008).
2. Ratko, T., Marbella, A., Godfrey, S. & Aronson, N. Enzyme-Replacement Therapies for Lysosomal Storage Diseases. Agency for Healthcare Research and Quality (US) ; Technical Brief No.: 12(13)-EHC154-EF.(2013). Available at:
http://www.ncbi.nlm.nih.gov/books/NBK117219/
. (Accessed: 24th November 2014).
3. Sandvig, K., Bergan, J., Kavaliauskiene, S. & Skotland, T. Lipid requirements for entry of protein toxins into cells. Prog. Lipid Res. 54C, 1–13 (2014).
4. Sandvig, K., Pust, S., Skotland, T. & van Deurs, B. Clathrin-independent endocytosis: mechanisms and function. Curr. Opin. Cell Biol. 23, 413–420 (2011).
5. Sandvig, K. & van Deurs, B. Membrane traffic exploited by protein toxins. Annu. Rev. Cell Dev. Biol. 18, 1–24 (2002).
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献